Literature DB >> 7871082

Lorazepam and diazepam effects on memory acquisition in priming tasks.

P Vidailhet1, J M Danion, F Kauffmann-Muller, D Grangé, A Giersch, M van der Linden, J L Imbs.   

Abstract

Unlike diazepam, lorazepam has repeatedly been shown to impair perceptual priming as well as explicit memory. To determine whether this deleterious effect was due to an impairment in acquisition of information, 60 healthy volunteers were randomly assigned to five treatment groups (placebo, lorazepam 0.026 or 0.038 mg/kg, diazepam 0.2 or 0.3 mg/kg) and successively performed perceptual priming tasks and a free-recall task. Priming performance on information learned before or 2 h after drug administration, i.e. at the peak concentration of lorazepam, was assessed under the influence of the drugs, using a picture-fragment and a word-stem completion task. Free-recall performance was altered by both drugs. Lorazepam decreased priming performance when information was acquired after, but not before, drug administration, indicating that the drug alters the acquisition of information. Lorazepam also impaired the ability to identify fragmented pictures, but there was no evidence that this perceptual effect accounts for the priming impairment. Surprisingly, diazepam also decreased priming when information was acquired after drug administration, suggesting that, at least in certain circumstances, the two benzodiazepines may exert similar effects on priming measures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871082     DOI: 10.1007/bf02245083

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Psychophysical evidence for low-level processing of illusory contours and surfaces in the Kanizsa square.

Authors:  B Dresp; C Bonnet
Journal:  Vision Res       Date:  1991       Impact factor: 1.886

Review 2.  Benzodiazepines and human memory: a review.

Authors:  M M Ghoneim; S P Mewaldt
Journal:  Anesthesiology       Date:  1990-05       Impact factor: 7.892

3.  Age-related changes in performance on a visual-closure task.

Authors:  D E Read
Journal:  J Clin Exp Neuropsychol       Date:  1988-08       Impact factor: 2.475

4.  Perceptual identification thresholds for 150 fragmented pictures from the Snodgrass and Vanderwart picture set.

Authors:  J G Snodgrass; J Corwin
Journal:  Percept Mot Skills       Date:  1988-08

5.  Effects of scopolamine, trimipramine and diazepam on explicit memory and repetition priming in healthy volunteers.

Authors:  J M Danion; M A Zimmermann; D Willard-Schroeder; D Grangé; M Welsch; J L Imbs; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Diazepam induces a dissociation between explicit and implicit memory.

Authors:  J M Danion; M A Zimmermann; D Willard-Schroeder; D Grangé; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  The nature of lorazepam-induced amnesia.

Authors:  R G Lister; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 8.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

9.  Diazepam and memory: evidence for spared memory function.

Authors:  J C Fang; J V Hinrichs; M M Ghoneim
Journal:  Pharmacol Biochem Behav       Date:  1987-11       Impact factor: 3.533

Review 10.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

View more
  10 in total

1.  Pharmacological modulation of behavioral and neuronal correlates of repetition priming.

Authors:  C M Thiel; R N Henson; J S Morris; K J Friston; R J Dolan
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  What makes lorazepam different from other benzodiazepines?

Authors:  S Pompéia; G M Manzano; S Tufik; O F A Bueno
Journal:  J Physiol       Date:  2005-12-01       Impact factor: 5.182

3.  Some facilitatory effects of lorazepam on dynamic visual binding.

Authors:  Mark A Elliott; Anne Giersch; Doerthe Seifert
Journal:  Psychopharmacology (Berl)       Date:  2005-12-23       Impact factor: 4.530

4.  Impairment of contrast sensitivity in long-term lorazepam users.

Authors:  Anne Giersch; Claude Speeg-Schatz; Monique Tondre; Sylvaine Gottenkiene
Journal:  Psychopharmacology (Berl)       Date:  2006-04-04       Impact factor: 4.530

5.  Midazolam does not inhibit association formation, just its storage and strengthening.

Authors:  Lynne M Reder; Iain Proctor; John R Anderson; Ferenc Gyulai; Joseph J Quinlan; Joyce M Oates
Journal:  Psychopharmacology (Berl)       Date:  2006-08-03       Impact factor: 4.530

6.  Lorazepam impairs perceptual integration of visual forms: a central effect.

Authors:  A Giersch; M Boucart; C Speeg-Schatz; F Muller-Kauffmann; J M Danion
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Effects of lorazepam and diazepam on conscious and automatic memory processes.

Authors:  P Vidailhet; M Kazès; J M Danion; F Kauffmann-Muller; D Grangé
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

8.  Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil.

Authors:  K I Bishop; H V Curran
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

9.  Effects of lorazepam on perceptual integration of visual forms in healthy volunteers.

Authors:  A Giersch; M Boucart; J M Danion; P Vidailhet; F Legrand
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

10.  Time course of the effects of diazepam and lorazepam on perceptual priming and explicit memory.

Authors:  F Legrand; P Vidailhet; J M Danion; D Grangé; A Giersch; M Van der Linden; J L Imbs
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.